— Know what they know.
Not Investment Advice

CNSL.L LSE

Cambridge Nutritional Sciences plc
1W: +9.7% 1M: -8.1% 3M: -2.9% YTD: -15.0% 1Y: -47.7% 3Y: -29.2% 5Y: -96.8%
£1.50 ($0.02)
-0.05 (-3.23%)
 
Weekly Expected Move ±14.2%
£1 £1 £2 £2 £2
LSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 40 · £3.7M mcap · 187M float · 0.147% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap£3.7M ($0.0M)
52W Range1.25-3
Volume53,518
Avg Volume275,982
Beta1.91
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames Cooper
Employees85
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2004-03-19
Websitecnsplc.com
One Fleet Place
London, GL EC4M 7WS
GB
+44 1353 661417
About Cambridge Nutritional Sciences plc

Established in 1987 and headquartered in London, UK, Cambridge Nutritional Sciences plc (formerly Omega Diagnostics Group PLC until its name change in September 2023) is a specialist in the development, manufacturing, and supply of medical diagnostic products. The company primarily operates within the food sensitivity testing market, creating and producing "Foodprint" branded kits designed to detect immune reactions to food. Beyond manufacturing, it provides clinical analysis services directly to the public, clinics, and healthcare professionals, and also offers the "Food Detective" consumer food test. Its diverse client base includes government entities, private hospitals, reference laboratories, nutritionists, naturopaths, and other medical practitioners. Cambridge Nutritional Sciences plc boasts a global presence, serving markets across the United Kingdom, continental Europe, North, South, and Central America, India, various other Asian countries and the Far East, Africa, and the Middle East.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms